This was an independent session organised by MGP without financial support or involvement from the pharmaceutical industry.
This site is intended for UK healthcare professionals
Related video
Dr Kevin Fernando Q&A on type 2 diabetes
Dr Kevin Fernando answers questions on the impact of type 2 diabetes on patients’ daily lives, differences between NICE and SIGN guidance, and key take-home messages for primary care
Latest video
Related articles
NewsNHS England appoints first female chief executive
Ms Pritchard takes over at the helm of NHS England during the third wave of COVID-19 and as the health system faces an unprecedented backlog of care
- News
Study finds extended interval for Pfizer/BioNTech vaccine boosts immune response
UK researchers have found that extending the time between doses of the Pfizer/BioNTech COVID-19 vaccine increases antibody levels compared with short dosing intervals
- NICE guideline
NICE type 1 diabetes guideline
This summary on type 1 diabetes in adults covers diagnosis, insulin therapy, and blood glucose management, and includes a useful algorithm
More Videos
- Video
Dr Glenis Scadding Q&A on rhinitis
This session was supported by an educational grant from Mylan Ltd. Dr Glenis Scadding comments on the main presentations of rhinitis, its impact on patients’ daily lives, red flags for referral, and the main recommendations of the 2017 BSACI guideline
- Video
Guidelines Live 2018 overview with Dr Matthew Fay
Dr Matt Fay, Chair of Guidelines Live 2018, provides his thoughts on the programme from a primary care perspective, and summarises the meetings.
No comments yet